Related Experiment Video
Updated: Dec 22, 2025
06:50
Analyzing Neural Activity and Connectivity Using Intracranial EEG Data with SPM Software
Published on: October 30, 2018
9.8K
Reply to Y. Usui et al
Ana Lluch1, Carlos H Barrios1, Laura Torrecillas1
1Ana Lluch, PhD, Hospital Clínico Universitario de Valencia, Valencia; Biomedical Research Institute INCLIVA, University of Valencia, Valencia; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid; and GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Carlos H. Barrios, MD, Centro de Pesquisa Clínica Hospital São Lucas da PUCRS; and LACOG, Latin American Cooperative Oncology Group, Porto Alegre, Brazil, Laura Torrecillas, MD, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Ciudad de México, México; and Miguel Martín, MD, PhD, Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII; GEICAM, Spanish Breast Cancer Group; and Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast Cancer.
Biomaterials research·2026
Same author
Factors associated with accepting chemotherapy despite the risk of fertility loss in Latin American breast cancer patients-LACOG 0414 study.
Therapeutic advances in medical oncology·2025
Same author
Main challenges to cancer care in Latin America: an analysis through breast cancer lenses.
Lancet regional health. Americas·2025
Same author
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial.
Nature medicine·2025
Same journal
Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal
Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026